Mapping single-cell transcriptomes in the intra-tumoral and associated territories of kidney cancer
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
T cell clonotypes largely defines their exhaustion state with intra-tumoral spatial heterogeneity that is not well explained by somatic heterogeneity. De novo mutation calling from single-cell RNA-sequencing data allows us to broadly infer the clonality of stromal cells and lineage-trace myeloid cell development. We report six conserved meta-programs that distinguish tumor cell function, and find an epithelial-mesenchymal transition meta-program highly enriched at the tumor-normal interface that co-localizes with IL1B-expressing macrophages, offering a potential therapeutic target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comprehensive Integration of Single-Cell Data
Stuart, T., Butler, A., Hoffman, P., Hafemeister, C., Papalexi, E., Mauck, W. M., Hao, Y., Stoeckius, M., Smibert, P., & Satija, R. (2019) · Cell · doi:10.1016/j.cell.2019.05.031 · Cited by 15,453
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
Inferring tumour purity and stromal and immune cell admixture from expression data
Yoshihara, K., Shahmoradgoli, M., Martínez, E., Vegesna, R., Kim, H., Torres-Garcia, W., Treviño, V., Shen, H., Laird, P. W., Levine, D. A., et al. (2013) · Nature Communications · doi:10.1038/ncomms3612 · Cited by 9,778 · cited 1×
“ccRCC is a cancer type with heavy infiltration of immune cells.(9,10) Harnessing adaptive immunity through immune checkpoint blockade (ICB) therapy is effective in improving the survival of patients,(11,12) highlighting the importance of the immunemicroenvironment of ccRCC.”
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774 · cited 2×
“Intra-tumoral heterogeneity (ITH) of these subsequent mutational events appears to be a salient feature of ccRCC, as revealed by previous multi-region exome sequencing studies.(5,7,8) In contrast, the ITH of ccRCC at a transcriptional level is less well understood, in part due to the complexity of”
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
Motzer, R. J., Escudier, B., McDermott, D. F., George, S., Hammers, H. J., Srinivas, S., Tykodi, S. S., Sosman, J. A., Procopio, G., Plimack, E. R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1510665 · Cited by 5,807
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Tirosh, I., Izar, B., Prakadan, S. M., Wadsworth, M. H., Treacy, D., Trombetta, J. J., Rotem, A., Rodman, C., Lian, C., Murphy, G., et al. (2016) · Science · doi:10.1126/science.aad0501 · Cited by 4,944 · cited 1×
“…in single-cell RNA sequencing (scRNA-seq) and its applications in cancer research have revolutionized our understanding of phenotypic heterogeneity of tumor cells, 15–17 immune landscape of tumors, 18–20 complexity and plasticity of the TME, 21,22 and inter-cellular communications in the TME.”
McGinnis, C. S., Murrow, L. M., & Gartner, Z. J. (2019) · Cell Systems · doi:10.1016/j.cels.2019.03.003 · Cited by 4,521
La Manno, G., Soldatov, R., Zeisel, A., Braun, E., Hochgerner, H., Petukhov, V., Lidschreiber, K., Kastriti, M. E., Lönnerberg, P., Furlan, A., et al. (2018) · Nature · doi:10.1038/s41586-018-0414-6 · Cited by 4,118
Comprehensive molecular characterization of clear cell renal cell carcinoma
The Cancer Genome Atlas Research Network (2013) · Nature · doi:10.1038/nature12222 · Cited by 3,485 · cited 1×
“To determine the likelihood of detecting expanded TCR clones in the blood as a function of pseudotime we computed the conditional density of detection of any cells with a given TCR in the blood, with pseudotime, for minimal clone sizes of 2, 4, 8, 16, 32, and 64 cells.”
Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma
Rini, B. I., Plimack, E. R., Stus, V., Gafanov, R., Hawkins, R., Nosov, D., Pouliot, F., Alekseev, B., Soulières, D., Melichar, B., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1816714 · Cited by 3,403
Generalizing RNA velocity to transient cell states through dynamical modeling
Bergen, V., Lange, M., Peidli, S., Wolf, F. A., & Theis, F. J. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0591-3 · Cited by 2,951
Puram, S. V., Tirosh, I., Parikh, A. S., Patel, A. P., Yizhak, K., Gillespie, S., Rodman, C., Luo, C. L., Mroz, E. A., Emerick, K. S., et al. (2017) · Cell · doi:10.1016/j.cell.2017.10.044 · Cited by 2,557
Tracking the Evolution of Non–Small-Cell Lung Cancer
Jamal-Hanjani, M., Wilson, G. A., McGranahan, N., Birkbak, N. J., Watkins, T. B. K., Veeriah, S., Shafi, S., Johnson, D. H., Mitter, R., Rosenthal, R., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1616288 · Cited by 2,349 · cited 1×
“Previous studies have extensively investigated intra-tumor genetic heterogeneity in various cancers.(8,34) However, the influence of somatic heterogeneity on the local TME at different spatial localizations, especially the anti-tumor immune response, remains largely uncharacterized.”
NicheNet: Modeling intercellular communication by linking ligands to target genes
Browaeys, R., Saelens, W., & Saeys, Y. (2020) · Nature Methods · doi:10.1038/s41592-019-0667-5 · Cited by 2,192 · cited 1×
“47 This analysis uses public databases (KEGG, ENCODE, PhoshoSite) to track downstream effectors such as transcription factors and receptor’s target in the provided dataset.”
Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment
Azizi, E., Carr, A. J., Plitas, G., Cornish, A. E., Konopacki, C., Prabhakaran, S., Nainys, J., Wu, K., Kiseliovas, V., Setty, M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.05.060 · Cited by 1,976
SoupX removes ambient RNA contamination from droplet-based single-cell RNA sequencing data
Young, M. D., & Behjati, S. (2020) · GigaScience · doi:10.1093/gigascience/giaa151 · Cited by 1,739 · cited 1×
“We used SoupX 59 to return an adjusted count matrix to account for ambient RNA contamination per channel using the adjustCounts() function.”
Self-citationSoupX removes ambient RNA contamination from droplet based single-cell RNA sequencing data
Young, M. D., & Behjati, S. (2018) · doi:10.1101/303727 · Cited by 1,648
Self-citationA pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells
Cheng, S., Li, Z., Gao, R., Xing, B., Gao, Y., Yang, Y., Qin, S., Zhang, L., Ouyang, H., Du, P., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.010 · Cited by 1,601 · cited 2×
“We found mast cells, which were characterized by specific expression of TPSAB1, potentially enriched in the tumor core (Figures 5B and S5B), consistent with previous reports.(39) Notably, we identified nine macrophage clusters (clusters 6–8 and 11–16) based on the high expression of CD163 and C1QC (Figure S5B).”
The origin and evolution of mutations in acute myeloid leukemia
Welch, J. S., Ley, T. J., Link, D. C., Miller, C. A., Larson, D. E., Koboldt, D. C., Wartman, L. D., Lamprecht, T. L., Liu, F., Xia, J., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.023 · Cited by 1,575
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
Jerby-Arnon, L., Shah, P., Cuoco, M. S., Rodman, C., Su, M.-J., Melms, J. C., Leeson, R., Kanodia, A., Mei, S., Lin, J.-R., et al. (2018) · Cell · doi:10.1016/j.cell.2018.09.006 · Cited by 1,429
Lipid-associated macrophages control metabolic homeostasis in a Trem2-dependent manner
Jaitin, D. A., Adlung, L., Thaiss, C. A., Weiner, A., Li, B., Descamps, H., Lundgren, P., Bleriot, C., Liu, Z., Deczkowska, A., et al. (2019) · Cell · doi:10.1016/j.cell.2019.05.054 · Cited by 1,377
Cell2location maps fine-grained cell types in spatial transcriptomics
Kleshchevnikov, V., Shmatko, A., Dann, E., Aivazidis, A., King, H. W., Li, T., Elmentaite, R., Lomakin, A., Kedlian, V., Gayoso, A., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-021-01139-4 · Cited by 1,279
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
Dalgliesh, G. L., Furge, K., Greenman, C., Chen, L., Bignell, G., Butler, A., Davies, H., Edkins, S., Hardy, C., Latimer, C., et al. (2010) · Nature · doi:10.1038/nature08672 · Cited by 1,173
Self-citationMultimodal Analysis of Composition and Spatial Architecture in Human Squamous Cell Carcinoma
Ji, A. L., Rubin, A. J., Thrane, K., Jiang, S., Reynolds, D. L., Meyers, R. M., Guo, M. G., George, B. M., Mollbrink, A., Bergenstråhle, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.039 · Cited by 1,117
Li, H., van der Leun, A. M., Yofe, I., Lubling, Y., Gelbard-Solodkin, D., van Akkooi, A. C. J., van den Braber, M., Rozeman, E. A., Haanen, J. B. A. G., Blank, C. U., et al. (2019) · Cell · doi:10.1016/j.cell.2018.11.043 · Cited by 1,101
Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
Bolli, N., Avet-Loiseau, H., Wedge, D. C., Van Loo, P., Alexandrov, L. B., Martincorena, I., Dawson, K. J., Iorio, F., Nik-Zainal, S., Bignell, G. R., et al. (2014) · Nature Communications · doi:10.1038/ncomms3997 · Cited by 875
Self-citationSingle-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors
Young, M. D., Mitchell, T. J., Vieira Braga, F. A., Tran, M. G. B., Stewart, B. J., Ferdinand, J. R., Collord, G., Botting, R. A., Popescu, D.-M., Loudon, K. W., et al. (2018) · Science · doi:10.1126/science.aat1699 · Cited by 762 · cited 2×
“25 Other studies utilized scRNA-seq to study the immune landscape of ccRCC, mainly focusing on ICB-therapy-related cohorts 26,27 and different disease stages, 28 uncovering key features that are related to therapeutic efficacy or disease progression.”
Self-citationIntegrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma
Clark, D. J., Dhanasekaran, S. M., Petralia, F., Pan, J., Song, X., Hu, Y., da Veiga Leprevost, F., Reva, B., Lih, T.-S. M., Chang, H.-Y., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.007 · Cited by 730 · cited 1×
“Characterizing this immune landscape using bulk sequencing is limited by the power to dissect diverse immune cell populations.(9,13) A comprehensive single-cell immuneatlas of ccRCCusingmasscytometry shed light on immune cell diversity in the ccRCC tumor ecosystem.”
Sharma, A., Seow, J. J. W., Dutertre, C.-A., Pai, R., Blériot, C., Mishra, A., Wong, R. M. M., Singh, G. S. N., Sudhagar, S., Khalilnezhad, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.040 · Cited by 677 · cited 1×
“…in single-cell RNA sequencing (scRNA-seq) and its applications in cancer research have revolutionized our understanding of phenotypic heterogeneity of tumor cells, 15–17 immune landscape of tumors, 18–20 complexity and plasticity of the TME, 21,22 and inter-cellular communications in the TME.”
Huang, H., Wang, C., Rubelt, F., Scriba, T. J., & Davis, M. M. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0505-4 · Cited by 484 · cited 1×
“We used the GLYPH2 algorithm to cluster TCRs that are predicted to recognize the same epitope.(35) In total, we detected six patterns that were shared between expanded clonotypes (Figure 4D).”
Kar, S. P., Quiros, P. M., Gu, M., Jiang, T., Mitchell, J., Langdon, R., Iyer, V., Barcena, C., Vijayabaskar, M. S., Fabre, M. A., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01121-z · Cited by 377 · cited 7×
“We used TCGA expression and prognostic data to calculate meta-programme scores and investigate how the meta-programmes correlate with survival of patients with ccRCC.”
Influential
Cited by
IL-1β+ macrophages fuel pathogenic inflammation in pancreatic cancer
Caronni, N., La Terza, F., Vittoria, F. M., Barbiera, G., Mezzanzanica, L., Cuzzola, V., Barresi, S., Pellegatta, M., Canevazzi, P., Dunsmore, G., et al. (2023) · Nature · doi:10.1038/s41586-023-06685-2 · Cited by 393
De novo detection of somatic mutations in high-throughput single-cell profiling data sets
Muyas, F., Sauer, C. M., Valle-Inclán, J. E., Li, R., Rahbari, R., Mitchell, T. J., Hormoz, S., & Cortés-Ciriano, I. (2024) · Nature Biotechnology · doi:10.1038/s41587-023-01863-z · Cited by 109
Self-citationDecoder-seq enhances mRNA capture efficiency in spatial RNA sequencing
Cao, J., Zheng, Z., Sun, D., Chen, X., Cheng, R., Lv, T., An, Y., Zheng, J., Song, J., Wu, L., et al. (2024) · Nature Biotechnology · doi:10.1038/s41587-023-02086-y · Cited by 71
“scRNA-seq reference data for ccRCC and chRCC were obtained from public databases 36,37,62 .”
Proteotoxic stress response drives T cell exhaustion and immune evasion
Wang, Y., Ma, A., Song, N.-J., Shannon, A. E., Amankwah, Y. S., Chen, X., Wu, W., Wang, Z., Saadey, A. A., Yousif, A., et al. (2025) · Nature · doi:10.1038/s41586-025-09539-1 · Cited by 68
Concurrent loss of the Y chromosome in cancer and T cells impacts outcome
Chen, X., Shen, Y., Choi, S., Abdel-Hafiz, H. A., Basu, M., Hoelzen, L., Tufano, M., Kailasam Mani, S. K., Ranjpour, M., Zhu, J., et al. (2025) · Nature · doi:10.1038/s41586-025-09071-2 · Cited by 50
“…61), SARC (sarcoma, 85), LIHC (214), TGCT (testicular germ cell tumours, 120), LGG (brain lower grade glioma, 262), LAML (acute myeloid leukemia, 63), THCA (thyroid carcinoma, 127), PRAD (prostate adenocarcinoma, 457), GBM (glioblastoma multiforme, 89), THYM (thymoma, 58), PCPG…”
Metadata
- Authors
- Li, R., Ferdinand, J. R., Loudon, K. W., Bowyer, G. S., Laidlaw, S., Muyas, F., Mamanova, L., Neves, J. B., Bolt, L., Fasouli, E. S., Lawson, A. R. J., Young, M. D., Hooks, Y., Oliver, T. R. W., Butler, T. M., Armitage, J. N., Aho, T., Riddick, A. C. P., Gnanapragasam, V., Welsh, S. J., Meyer, K. B., Warren, A. Y., Tran, M. G. B., Stewart, G. D., Cortés-Ciriano, I., Behjati, S., Clatworthy, M. R., Campbell, P. J., Teichmann, S. A., & Mitchell, T. J.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2022-12
- Volume
- 40
- Issue
- 12
- Pages
- 1583-1599.e10
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W4309825858
- Cited by
- 244
- References
- 31
- FWCI
- 12.91
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.